TCI Wealth Advisors’s Coherus Oncology CHRS Stock Holding History

TCI Wealth Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-231	Closed	-$4K	–	2258
2021 Q4	$4K	Hold	231	–	–	﹤0.01%	1785
2021 Q3	$4K	Sell	231 -53	-19%	-$777	﹤0.01%	1715
2021 Q2	$4K	Buy	284 +167	+143%	+$2.37K	﹤0.01%	1543
2021 Q1	$2K	Buy	+117	New	+$1.99K	﹤0.01%	1695
2018 Q4	–	Sell	-12	Closed	–	–	1467
2018 Q3	$0	Sell	12 -22	-65%	-$390	﹤0.01%	1474
2018 Q2	$0	Buy	+34	New	+$487	﹤0.01%	1512

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TCI Wealth Advisors's CHRS Position: Q1 2022 in Review

TCI Wealth Advisors sold out of Coherus Oncology (CHRS) in Q1 2022, closing a stake of 231 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in CHRS in Q2 2018 and held it in 6 quarters. The position peaked at $4K in Q4 2021. 183 funds tracked by Wall St. Rank hold CHRS as of Q1 2022.

TCI Wealth Advisors reported no remaining Coherus Oncology position as of Q1 2022 after selling out during the quarter.
TCI Wealth Advisors sold 231 Coherus Oncology shares in Q1 2022, an estimated $4K.
TCI Wealth Advisors first reported a position in Coherus Oncology in Q2 2018 and held it in 6 quarters.
TCI Wealth Advisors's Coherus Oncology position peaked at $4K in Q4 2021.
183 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2022.

Based on TCI Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.